From the Cardiovascular Division and Howard Hughes Medical Institute,
Brigham and Women's Hospital (D.W.B., D.F., C.T.B., B.M., C.E.S.), the
Department of Genetics, Howard Hughes Medical Institute (J.G.S.), and the
Department of Cardiology, Children's Hospital (P.L.), Boston, Mass; and
the Division of Pediatric Cardiology, Washington University, St Louis, Mo
(A.S., A.W.S.).
Correspondence to D. Woodrow Benson, MD, PhD, Director, Cardiovascular Genetics, Pediatric Cardiology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425-0680.
Methods and ResultsClinical evaluation of three families
identified individuals with ASD in multiple generations. ASD was
transmitted as an autosomal dominant trait in each family. ASD was the
most common anomaly, but other heart defects occurred alone or in
association with ASD in individuals from each kindred. Genome-wide
linkage studies in one kindred localized a familial ASD disease gene to
chromosome 5p (multipoint LOD score=3.6,
ConclusionsFamilial ASD is a genetically
heterogeneous disorder; one disease gene maps to chromosome
5p. Recognition of the heritable basis of familial ASD is complicated
by low disease penetrance and variable expressivity. Identification
of ASD or other congenital heart defects in more than one family member
should prompt clinical evaluation of all relatives.
Some individuals with secundum ASD have a family history of this defect
or other congenital heart malformations, and coexisting heart block has
been observed in some familial ASD kindreds.4 The
genetic basis, if any, for these clinical observations remains unclear.
Although an autosomal dominant mode of inheritance for familial ASD has
been described in a few families,4 the incidence
of ASD in siblings1 5 and
offspring1 6 of affected individuals is often
less than that expected for single gene defects, and multifactorial
models of inheritance have also been
postulated.1
To identify the genetic basis for familial ASD, we clinically evaluated
and genetically studied three kindreds with ASD inherited as an
autosomal dominant trait. We report a disease locus for familial ASD on
the telomeric region of chromosome 5p and demonstrate that this
disorder is genetically heterogeneous. Disease penetrance
was incomplete (the absence of a clinical phenotype in
individuals bearing the gene mutation), and some genetically affected
individuals exhibited other structural heart defects. We suggest that
incomplete penetrance and variable expressivity of familial ASD may
result in a significant underestimate of the heritable nature of this
condition.
Genetic Analysis
Two-point linkage analyses were performed by use of MLINK
(version 5.1) with allele frequencies determined from family
members and a phenocopy rate of 0.001. Multipoint analysis was
performed with LINKAGE. Genetic heterogeneity for
familial ASD in the study kindreds was assessed by use of HOMOG
program.
Eighteen members from three generations of family MBE were clinically
evaluated. Six individuals had a secundum ASD (Fig 1B
Twenty-three members from four generations of family MXP were
clinically evaluated. Eight individuals (Fig 1C
Genetic Analysis
Linkage studies were performed in family MAR to define the chromosomal
location of a mutation causing familial ASD. Because disease penetrance
was recognized to be incomplete, initial linkage studies
analyzed only the genotypes of individuals with an ASD
or individuals whose offspring had an ASD. Accordingly, disease
penetrance was set at 100%. A total of 125 polymorphic short
tandem repeat sequences distributed across the genome were tested, and
A disease haplotype in family MAR was constructed from the
genotypes of individuals with ASD at 13 loci near
ASD1 and compared with the genotypes of all family
members (Fig 1A
The disease interval defined by the haplotypes of individuals with
secundum ASD spans an 11-cM region between D5S2088 and
D5S807 (Fig 4
To determine whether the disease gene in family MAR was also
responsible for the heritable cardiovascular disorders
in families MBE and MXP, linkage was assessed at the ASD1
locus only in individuals with ASD or individuals whose offspring had
an ASD. Two-point LOD scores achieved in family MBE and family MXP were
less than -2.0 across the interval between D5S2088 and
D5S630 (Fig 4
Diversity of clinical phenotype combined with generational
skips has led to the hypothesis that the etiology of congenital heart
disease is multifactorial and due to interaction of complex (polygenic)
traits and environmental factors.1 The three
families studied here typify the difficulties of assessing the
heritable nature of congenital heart disease. Although pedigree
analyses (Fig 1
Diagnostic techniques used in this study could have
contributed to an underestimate of phenotype. For example,
transesophageal echocardiography is
recognized to be more sensitive and specific than
transthoracic echocardiography in
identifying abnormalities of the atrial septum, especially in large
adults.15 Although
transesophageal echocardiography
may have increased the diagnostic yield for subtle
malformations such as atrial septal aneurysm, it is unlikely to
have changed the principal findings of this study. Alternatively, the
clinical status of individuals carrying mutations at ASD1
may change. For example, because ASD is one of several congenital
malformations that can "spontaneously"
resolve,8 16 evaluations performed after
spontaneous closure would inaccurately assign an unaffected status and
thereby contribute to the impression of reduced gene penetrance. The
basis for reduced penetrance has not been established, but this
phenomenon is associated with other congenital cardiac
malformations.17 18
Genetic studies in family MAR further indicated that the
ASD1 gene mutations accounted for several other
cardiovascular malformations present in family
members. Although secundum ASD was the most common cardiac malformation
in family MAR and two other study kindreds, patent ductus arteriosus,
ventricular septal defect, atrial septal aneurysm,
left superior vena cava, tetralogy of Fallot, bicuspid aortic valve,
valvular or subvalvular aortic stenosis, and AV
conduction abnormalities were also observed. These families are
representative of other kindreds with familial
ASD19 20 21 22 23 24 in which as many as 40% of individuals
had additional or other cardiac anomalies. The identification of a
common haplotype in family MAR individuals with distinct congenital
heart defects may indicate that variable expressivity of a single
gene defect can account for clinical diversity of congenital heart
disease in a family. Diverse cardiac malformations are recognized in
other monogenic human disorders, including Holt-Oram
syndrome25 26 27 28 and chromosome 22q11
microdeletions,29 and also occur in retinoic X
receptordeficient mice.30 Although variable
expressivity is not a feature predicted by classic embryological models
of cardiac development, heritable monogenic mutations can clearly cause
pleiomorphic cardiovascular defects.
Although ASD causes no obvious deleterious effect during fetal
development, the consequences of these defects during postnatal life
are variable.2 Uncorrected ASD can lead to
symptoms due to pulmonary overcirculation and right heart
volume overload. However, spontaneous closure in the first few years of
life has been well documented, with no apparent long-term
sequelae.8 16 The association of atrial septal
aneurysm and secundum ASD has led to the suggestion that
aneurysms are a congenital malformation of the
septum7 that may play a role in postnatal ASD
closure.8 Genetic studies in family MAR support
this cause-and-effect relationship in that a disease haplotype
identified in individuals with secundum ASD was also found in two
individuals (V-1, V-7) with atrial septal aneurysm. Serial
studies of these individuals may help to define postnatal changes in
the atrial septum.
Embryological models of secundum ASD have emphasized abnormal
development of the septum primum, but little is known of the molecular
basis of atrial septation. No obvious candidate genes have been mapped
to ASD1, but it is noteworthy that large deletions of
chromosome 5p cause cri-du-chat syndrome, a contiguous-gene syndrome
occasionally associated with congenital heart
disease.31 Definition of the ASD1 gene
may also help to elucidate the molecular basis for cardiac
malformations in this syndrome. Identification of this and other
familial ASD genes should provide new insights into the important steps
in cardiac morphogenesis leading to atrial septation.
The contribution of familial ASD gene defects to the incidence of
congenital heart disease remains unknown. Given the variable
expression and low penetrance of the ASD gene mutations described here,
an individual bearing one of these gene defects might present as an
isolated case. When family history reveals a congenital heart disorder
in more than one individual, clinical and genetic evaluations of all
family members are recommended.
Received October 22, 1997;
revision received January 15, 1998;
accepted January 23, 1998.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Reduced Penetrance, Variable Expressivity, and Genetic Heterogeneity of Familial Atrial Septal Defects
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
BackgroundSecundum atrial septal
defect (ASD) is a common congenital heart malformation that occurs as
an isolated anomaly in 10% of individuals with congenital heart
disease. Although some embryological pathways have been elucidated, the
molecular etiologies of ASD are not fully understood. Most cases of ASD
are isolated, but some individuals with ASD have a family history of
this defect or other congenital heart malformations.
=0.0). Assessment of 20
family members with the disease haplotype revealed that 9 had ASD, 8
were clinically unaffected, and 3 had other cardiac defects (aortic
stenosis, atrial septal aneurysm, and persistent left
superior vena cava). Familial ASD did not map to chromosome 5p in two
other families.
Key Words: echocardiography genetics heart septal defects
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
Secundum atrial
septal defect (ASD) is a common congenital heart malformation
accounting for 10% of isolated congenital heart
disease.1 2 Uncorrected ASD can cause
pulmonary overcirculation, right heart volume overload, and
premature death. Models of cardiac embryogenesis have suggested that
this defect is caused by malformation of the septum primum, resulting
in incomplete coverage of the ostium secundum (fossa
ovalis).3 However, neither the cellular
mechanisms nor molecular signals directing these processes are
known.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Clinical Evaluation
Informed consent was obtained from all participants in
accordance with the Brigham and Women's Hospital Committee of the
Protection for Human Subjects From Research Risks. Family members in
three unrelated kindreds were evaluated by history, review of medical
records, physical examination, 12-lead ECG, and two-dimensional
transthoracic echocardiography with
color flow Doppler interrogation in four standard and subcostal
views. Cardiac catheterization and
transesophageal echocardiography
had been performed in some individuals. ASD and other malformations
were diagnosed by standard criteria; atrial septal aneurysms
were diagnosed by previously established
criteria.7 8 Clinical studies were performed
without knowledge of genotype.
Genomic DNA was isolated from peripheral lymphocytes
as previously described.9 Polymorphic short
tandem repeat sequences with heterozygosity >0.7 and four or more
alleles were chosen from each chromosome at
30-centimorgan (cM)
intervals and amplified from genomic DNA by the polymerase chain
reaction. In brief, 100 ng of genomic DNA was amplified in a volume of
10 µL containing 40 ng of unlabeled oligonucleotide
primer, 40 ng of primer end-labeled with 32P,
200 mmol/L each of dATP, dCTP, dGTP, and dTTP, and Taq
polymerase. The samples were denatured for 2 minutes at 95°C, then
processed through 35 cycles including denaturation at 95°C for 20
seconds, primer annealing at 58°C for 30 seconds, and primer
extension at 72°C for 40 seconds. The amplified products were
electrophoresed on 6% polyacrylamide sequencing gels and
visualized by autoradiography.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Clinical Evaluation
Seventy individuals from four generations of family MAR were
clinically evaluated. In nine individuals, a secundum ASD had been
previously identified (Fig 1A
and
Table
). Surgical closure of an ASD had been performed in
7 individuals: surgery occurred between ages 22 and 44 years in 6
individuals and at age 4 years in 1 individual. Secundum ASD was
documented at autopsy in individual IV-12 (at age 34 years) and at
cardiac catheterization in individual IV-10 (performed
at age 63 years). Clinical evaluations in other family members
demonstrated an atrial septal aneurysm in individuals V-1 and
VI-7 (Fig 3
) and a persistent left superior vena cava in individual V-1
(Fig 3
). An echocardiographic diagnosis of moderate
valvular aortic stenosis was made in individual IV-4;
the etiology of aortic stenosis was limited by the extent of
valve calcification and technical difficulties. However, given the
relatively young age at diagnosis (previously diagnosed at age 54
years), it is most likely that this individual has a bicuspid aortic
valve.10 The clinical status of individual III-1
before his death is unknown.

View larger version (41K):
[in a new window]
Figure 1. Pedigrees of kindreds with familial secundum
atrial septal defect (ASD). Secundum ASD (solid symbols) was
present in nine individuals from family MAR (A). Three individuals
had other cardiac malformations (partially solid symbols). Individuals
without structural heart defects (open symbols) or with unknown
clinical status (shaded symbols) are shown. Genotypes for 13
polymorphic loci on chromosome 5 are provided. Haplotype
segregating with ASD is enclosed in a box. Secundum ASD in family MBE
(B) and family MXP (C) was also inherited as an autosomal dominant
trait. Affection status is denoted as in A.
View this table:
[in a new window]
Table 1. Clinical Characteristics of Familial ASD

View larger version (39K):
[in a new window]
Figure 3. Transesophageal
echocardiography in individual V-1 (family MAR)
demonstrated atrial septal aneurysm (A). B, Injection of saline
into left brachial vein identified flow into coronary sinus
(CS) and right atrium (RA), indicating persistent left superior vena
cava (LSVC) (diagrammed in C). LA indicates left atrium; RV, right
ventricle.
and Table
).
Diagnosis was made before the age of 5 years in 4 individuals and
resulted in surgical closure of the ASD during the first decade of
life. Individuals III-2 and IV-8 were diagnosed with an ASD in
adulthood and underwent surgical closure at ages 40 and 32 years,
respectively. Four individuals had other structural heart defects. A
patent ductus arteriosus was diagnosed in individual IV-2 at 6 months
(ligated at age 3.5 years) and in individual V-1 (ligated at age 5
years). Individual III-3 had a stenosed bicuspid aortic valve and
underwent aortic valve replacement at age 56 years. A bicuspid aortic
valve was diagnosed in his son (individual IV-3) at age 37 years.
and Table
) were
previously recognized to have secundum ASD and prolonged AV
conduction.11 12 One individual (IV-7) had
isolated second-degree AV block; transesophageal
echocardiography demonstrated normal cardiac
structures. Other structural heart abnormalities found in family
members included subvalvular aortic stenosis
(individual III-3), ventricular septal defect (individuals
IV-10 and V-1), tetralogy of Fallot (individuals IV-8 and IV-12), and
pulmonary atresia (individual IV-8). Affected family members in
generations II and III were diagnosed after age 30 years; however,
cardiac malformations in subsequent generations were recognized by age
4 years.
In each family, pedigree evaluations suggested that an autosomal
dominant trait caused inherited ASD and other structural heart defects.
Only 9 secundum ASDs were identified in the MAR kindred, and disease
penetrance appeared incomplete. For example, the incidence of ASD in
the offspring of these 9 affected individuals was
33% and was less
than expected for a fully penetrant dominant trait. Furthermore,
individual IV-2 provided a clear example of nonpenetrance. Although
this woman is clinically unaffected, one son (V-4) had a secundum ASD
(Fig 2
) and another (V-1) has an atrial
septal aneurysm and persistent left superior vena cava (Fig 3
).

View larger version (77K):
[in a new window]
Figure 2. Transesophageal echocardiogram in
individual V-4 (family MAR). Two-dimensional
echocardiographic images demonstrated secundum atrial
septal defect (ASD) (A) with left atrial to right atrial blood flow on
color Doppler interrogation (B). Ao indicates aortic root; LA, left
atrium; and RA, right atrium.
25% of the genome was eliminated before linkage was detected at
D5S208. Linkages to nearby loci on the distal arm of
chromosome 5p were then assessed. A maximum 2-point logarithm of the
odds (LOD) score of 2.83 (
=0.0) was detected at D5S406,
and a maximum multipoint LOD score of 3.6 was obtained (Fig 4
). The familial ASD locus on chromosome
5p was designated ASD1.

View larger version (18K):
[in a new window]
Figure 4. Multipoint LOD score in family MAR defines
ASD1 locus between D5S2088 and
D5S807 (top). Cardiac defects in family MBE or family
MXP are not caused by mutations at this locus (LOD scores <-2.0).
Haplotype analysis of individuals with secundum ASD (V-4,
III-3) and atrial septal aneurysm (V-1) indicate recombination
events (solid box) that refine the ASD1 locus to a 4-cM
interval between D5S635 and D5S807.
). The haplotypes of individuals III-1, IV-3, IV-10, and
IV-12 were reconstructed from the alleles of offspring and spouses.
Twenty-one individuals exhibited the disease haplotype, including all
members of family MAR with structural heart disease (9 individuals with
secundum ASD, 1 with atrial septal aneurysm, 1 with atrial
septal aneurysm and persistent left superior vena cava, and 1
with valvular aortic stenosis). The disease haplotype
was also found in 1 deceased individual (clinical status before death
unknown) and 8 clinically unaffected individuals. Based on this disease
haplotype, the penetrance of secundum ASD was 45%; the penetrance for
secundum ASD or atrial septal aneurysm was 55%.
). However, because the disease haplotype was
identified in two individuals (VI-7 and V-1) with atrial septal
aneurysms, we hypothesized that this pathological condition
might represent a form fruste or spontaneous closure of an
unrecognized ASD. The haplotype of individual V-1 exhibits a
recombination event that refines the disease interval to a 4-cM region
between D5S635 and D5S807. LOD scores were also
calculated including individuals with atrial septal aneurysms
as affected. This maximum 2-point LOD score was 2.83 (
=0) at
D5S208 and the maximum multipoint LOD score 3.9, indicating
odds of
8000:1 that the disease gene in family MAR is genetically
linked to loci on chromosome 5p.
), indicating that the ASD gene in these
families did not map to the ASD1 locus. The HOMOG program
provided further evidence of heterogeneity, because
heart defects in families MBE and MXP are unlikely to be due to
mutations in ASD1 on chromosome 5p (P<.001, data
not shown).
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
We demonstrate that familial ASD can be caused by a gene mutation
on chromosome 5p. This disorder is genetically
heterogeneous and can also be caused by defects in other
undefined genes. In addition to secundum ASD, clinical manifestations
of the ASD1 gene include other frequently occurring
cardiovascular malformations; atrial septal
aneurysms, venous anomalies (persistent left superior vena
cava), and aortic valve disease (bicuspid aortic valve) occur in
0.5% to 1% of the population and could have occurred by chance in
some family members.7 8 13 14 However, the chance
of three cardiac anomalies arising concurrently in three family members
with the ASD1 gene by chance alone is very small. We suggest
that mutations in familial ASD genes cause a broad spectrum of
hereditary congenital cardiovascular disorders.
) suggested that an autosomal dominant trait
segregated in each family, this model also requires incomplete
penetrance and variable expressivity to account for the clinical
status of all family members. The disease haplotype (Fig 1A
) defined by
linkage studies of affected members in family MAR confirmed this model.
Incomplete penetrance, inaccurate diagnosis, or age-dependent
phenotype are assumed to account for eight clinically
unaffected individuals who carried the disease haplotype.
![]()
Acknowledgments
These studies were supported in part by grants from the Feinberg
Cardiovascular Research Institute, Northwestern
University, Chicago, Ill (D.W.B.), Walden W. and Jean Young Shaw
Foundation (D.W.B.), National Institutes of Health (HL-0946101)
(D.W.B.), National Institutes of Health (K08-HL-03468) (C.T.B.), and
Howard Hughes Medical Institute (D.F., B.M., J.G.S., C.E.S.). We are
indebted to family members for their participation. These studies would
not have been possible without the skillful assistance of Mohammed
Miri, Susanne Bartlett, Tim Sekarski, and Deborah Hicks.
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
/ß
cardiac myosin heavy chain hybrid gene. Cell. 1990;62:991998.[Medline]
[Order article via Infotrieve]
deficiency confers genetic susceptibility for
aortic sac, conotruncal, atrioventricular cushion, and
ventricular muscle defects in mice. J Clin
Invest. 1996;98:13321343.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
H. Matsson, J. Eason, C. S. Bookwalter, J. Klar, P. Gustavsson, J. Sunnegardh, H. Enell, A. Jonzon, M. Vikkula, I. Gutierrez, et al. Alpha-cardiac actin mutations produce atrial septal defects Hum. Mol. Genet., January 15, 2008; 17(2): 256 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caputo, G. Capozzi, M. G. Russo, T. Esposito, L. Martina, D. Cardaropoli, C. Ricci, P. Argiento, G. Pacileo, and R. Calabro Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect Eur. Heart J., October 2, 2005; 26(20): 2179 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
P T Wilmshurst, M J Pearson, S Nightingale, K P Walsh, and W L Morrison Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura Heart, November 1, 2004; 90(11): 1315 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cripe, G. Andelfinger, L. J. Martin, K. Shooner, and D. W. Benson Bicuspid aortic valve is heritable J. Am. Coll. Cardiol., July 7, 2004; 44(1): 138 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Okubo, O Miyoshi, K Baba, M Takagi, K Tsukamoto, A Kinoshita, K Yoshiura, T Kishino, T Ohta, N Niikawa, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family J. Med. Genet., July 1, 2004; 41(7): e97 - e97. [Full Text] [PDF] |
||||
![]() |
D. A. Elliott, E. P. Kirk, T. Yeoh, S. Chandar, F. McKenzie, P. Taylor, P. Grossfeld, D. Fatkin, O. Jones, P. Hayes, et al. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2072 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hobbs, M. A. Cleves, and C. J. Simmons Genetic Epidemiology and Congenital Malformations: From the Chromosome to the Crib Arch Pediatr Adolesc Med, April 1, 2002; 156(4): 315 - 320. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |